We’re excited to share this conversation with our Chief Scientific Officer, Adrian Owen OBE, FRS, FRSC. FCAHS, PhD, on VBC One with Dr. Shannon I. Decker, PhD., MBA, MBA, M.Ed., M.Ed., exploring how neuroscience is advancing cognitive care—from ICU awareness to early detection of dementia and long COVID. ⭐ Prof. Owen highlights how the science behind Creyos makes brain function measurement more sensitive, specific, and accessible, enabling proactive, value-based care at scale. Catch the full discussion here: https://lnkd.in/edUWh-ik
Innovating Healthcare Executive | Deep Experience in Value Based Care Success | Founder & CEO | VBC One – Modern MSO for Delegated Risk | Risk Adjustment, Quality, Compliance, TCOC | Reimagining Provider Enablement
🎙️ New VBC One • One Take: The Neuroscience of Awareness, Aging & Early Detection — with Dr. Adrian Owen OBE, FRS, FRSC. FCAHS, PhD (Chief Scientific Officer, Creyos) I sat down with world-renowned neuroscientist Dr. Adrian Owen to explore how brain science is reshaping care—from ICU prognostication to dementia detection and long COVID. Why this episode matters, 🧠 In 2006, Dr. Owen’s fMRI work revealed conscious awareness in patients previously labeled “vegetative,” transforming bedside practice and ethics. One recovered patient told him: “The day you scanned me, I went from being a thing to being a person.” 📠 Beyond imaging, his team’s cognitive science underpins Creyos—a 35-year lineage of tests designed to measure brain function (not just performance), enabling more sensitive early detection and more specific differentiation across conditions. 💼 We unpack how this helps clinicians spot subtle change sooner (ADHD, MCI → dementia trajectories), distinguish vascular vs. Alzheimer’s patterns, and separate cognitive long-COVID from mood impacts. 🤝 Accessibility matters: self-administered, multi-language, browser-based assessments make longitudinal tracking feasible at scale—fueling better prediction with privacy-safe, high-volume data. 🎩 Top takeaways 🥸 Assume awareness, unless proven otherwise. Treatment, communication, and decisions must reflect that. 🌡️ Sensitivity + specificity beat “checklist” screens—earlier, clearer signals drive better next steps. 🔮 Prediction > labels. We may not “diagnose” with a single test, but we can forecast who will meet criteria and intervene sooner. 💪 Aging population ≠ inevitable decline. Early detection supports clinical action and life planning. 😷 Long COVID is plural. Cognitive effects and anxiety/depression can be distinct—and require tailored approaches. If you care about value-based care, brain health, or scaling proactive screening, this conversation is for you. 🎧 Listen to the entire interview on You Tube now or watch for "One Take" episodes to be aired here, on my page, all week: https://lnkd.in/gigmqYGS ⭐ Want to be a guest on our podcast? Sign up here: https://lnkd.in/dfSpXV-S ⭐ Have an idea for a future topic? Send it to [email protected] ⭐ NEVER MISS an episode. Subscribe today! www.youtube.com/@VBCOne 👍 Like for content ♻️ Repost if this helped or inspired 🔔 Follow me, Dr. Shannon I. Decker, PhD., MBA, MBA, M.Ed., M.Ed., & my company, VBC One, for more insights on risk, quality, & value-based care. #Neuroscience #CognitiveHealth #Dementia #Alzheimers #LongCOVID #BrainInjury #fMRI #CognitiveAssessment #DigitalHealth #PopulationHealth #ValueBasedCare #VBCA #Creyos #AdrianOwen #VBCOne #OneTake #ProactiveCare #AgingWell #PredictionNotJustDiagnosis